|
National Stock Number(NSN): 6505-01-326-3240 (6505013263240, 013263240)
| NIIN: |
01-326-3240 |
Item Name: |
SALICYLIC ACID SOLUTION |
INC: |
35955
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
35955 |
| ISC: |
2 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Dec-01-1993 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
90-0699 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC52761-0121-15 |
77491
|
MEDICIS PHARMACEUTICAL CORP MEDICIS DERMATOLOGICS |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
OCCLUSAL |
77491
|
MEDICIS PHARMACEUTICAL CORP MEDICIS DERMATOLOGICS |
H |
5 |
1 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
M |
|
1 |
|
$3.07 |
BT |
|
C2201X- |
|
H |
| DN |
JDC |
L |
|
M |
|
1 |
|
$9.38 |
BT |
|
9L----- |
|
H |
| DS |
JDC |
L |
|
M |
|
1 |
|
$9.38 |
BT |
|
------- |
|
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
15 ML |
|
|
|
|
| DN |
K |
15 ML |
|
|
|
|
| DS |
K |
15 ML |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
17.000 PERCENTAGE,W/V SALICYLIC ACID ACTIVE INGREDIENT |
| AKJQ |
PHARMACEUTICAL VEHICLE TYPE |
POLYACRYLIC |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE WITH APPLICATOR,BRUSH |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
15.000 MILLILITERS OR 0.500 FLUID OUNCES |
| FEAT |
SPECIAL FEATURES |
10 PCT V/V ISOPROPYL ALCOHOL |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
|
3 |
Z |
|
|
|
|
| FSKX |
|
|
3 |
Z |
|
|
|
|
| N9LM |
|
|
3 |
Z |
|
|
|
|
|